Sofosbuvir 3′,5′-Bis-O-Phosphoramidate alpha-Isomer

Home / Products / S / Sofosbuvir / Sofosbuvir 3′,5′-Bis-O-Phosphoramidate alpha-Isomer

Sofosbuvir 3',5'-Bis-O-Phosphoramidate alpha-Isomer

Product Description

CAT No.

ALN-S010012

CAS No.

Mol. F.

C35H47FN4O12P2

Mol. Wt.

796.7

Stock

Please Inquire

Sofosbuvir 3',5'-Bis-O-Phosphoramidate alpha-Isomer quantity

RFQ

Product Overview

Technical Data

Reference

RFQ

Product Overview

Chemical Name : Isopropyl ((R)-benzyl(((2R,3R,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-(((S)-(((S)-1-isopropoxy-1-oxopropan-2-yl)amino)(phenoxy)phosphoryl)oxy)-4-methyltetrahydrofuran-2-yl)methoxy)phosphoryl)-L-alaninate

Smiles : F[C@]1(C)[C@H](O[P@](OC2=CC=CC=C2)(N[C@@H](C)C(OC(C)C)=O)=O)[C@@H](CO[P@](CC3=CC=CC=C3)(N[C@H](C(OC(C)C)=O)C)=O)O[C@@H]1N4C(NC(C=C4)=O)=O

Technical Data

Reference

Method development and validation for the simultaneous estimation of sofosbuvir and velpatasvir in bulk and tablet dosage forms by RP-HPLC

By Suma, M. S. M.; Gowthami, M.; Latha, P. V. Madhavi; Devi, P. UmanFrom Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9037-9043.

Development and validation of RP-HPLC method for the estimation of Sofosbuvir and Ledipasvir in combined dosage form

By Prabhaker, Naik Desai Prabhat; Pankaj, Kapupara – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2021), 12(1), 523-529.